Teladoc Health: Performance of Integrated Care and BetterHelp Are Encouraging Factors In 2024 & Beyond! 

Teladoc health has shown growth in the previous year’s earnings with an increased focus on operating efficiencies and bottom line performance. The company delivered 33% growth in adjusted EBITDA and free cash flow of $194 million in 2023. Their selling season yielded double-digit bookings growth over the prior year, with around 75% being upsells or expansions with existing clients. While this year’s plan is to grow adjusted EBITDA margins and free cash flow while continuing its investment in innovation, Teladoc Health also intends to remove more than $85 million in expenses through efficiencies and restructuring.